Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist

Details for Australian Patent Application No. 2009247021 (hide)

Owner Pulmagen Therapeutics (Synergy) Limited AstraZeneca AB

Inventors Mather, Andrew; Ford, Rhonan; Wiley, Katherine; Mete, Antonio; Bull, Richard, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009247021

PCT Pub. Number WO2009/139708

Priority 0808710.8 13.05.08 GB; 0900563.8 14.01.09 GB

Filing date 12 May 2009

Wipo publication date 19 November 2009

Acceptance publication date 7 June 2012

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/139708 Priority application(s): WO2009/139708

7 June 2012 Application Accepted

  Published as AU-B-2009247021

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009247029-Self closing flood barrier and method for protecting a hinterland using same

2009247018-A bottom-hole assembly, and a method and system for transmitting data from a bottom-hole assembly